血液管理市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、組件、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球血液管理市場規模為136.2億美元，預計到2030年將以6.90%的複合年成長率成長至203.3億美元。全球血液管理市場涵蓋了從捐血者招募和採集到處理、檢測、儲存和輸血等一系列流程和技術，旨在確保安全、充足和高效的血液供應，其中包括先進的患者血液管理策略。推動市場擴張的關鍵因素包括：需要輸血的慢性疾病發生率不斷上升、全球外科手術量不斷成長以及老年人口不斷增加，而老年人口本身也更容易患上需要輸血的疾病。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球血液管理市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品分類（儀器、配件、試劑及試劑盒、軟體）
  • 依成分（全血、紅血球、血漿）
  • 按最終使用者（血庫、醫院、診斷診所、病理實驗室）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美血液管理市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲血液管理市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太血液管理市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲血液管理市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲血液管理市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球血液管理市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMerieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, SA
• F. Hoffmann-La Roche Ltd.

第16章：策略建議

第17章調查會社について,免責事項

The Global Blood Management Market, valued at USD 13.62 Billion in 2024, is projected to experience a CAGR of 6.90% to reach USD 20.33 Billion by 2030. The global blood management market encompasses the comprehensive set of processes and technologies involved in ensuring a safe, adequate, and efficient blood supply from donor recruitment and collection to processing, testing, storage, and transfusion, including advanced patient blood management strategies. Key drivers supporting market expansion include the increasing incidence of chronic diseases requiring transfusions, a rising volume of surgical procedures worldwide, and the growing elderly population predisposed to conditions necessitating blood products.

Key Market Drivers

The rising prevalence of chronic diseases and blood disorders profoundly drives demand within the global blood management market. Conditions such as sickle cell disease, thalassemia, and various cancers necessitate frequent transfusions and specialized blood products for patient survival and improved quality of life. For example, according to Frontiers in Public Health, August 27, 2024, "Sickle cell disease: a comparative perspective on global and national initiatives," approximately 300,000 infants are born annually with Sickle Cell Disease globally, primarily in sub-Saharan Africa, India, and the Middle East, establishing a continuous requirement for blood components. This pervasive need creates an expanding base for the blood management sector.

Key Market Challenges

A critical challenge impeding the growth of the global blood management market stems from the consistent need to maintain a sufficient and safe blood supply. This challenge is exacerbated by evolving donor demographics and increasingly stringent regulatory requirements, directly impacting the ability of blood establishments to sustain robust donor recruitment and retention programs. The fluctuations in donor availability necessitate significant operational investments in outreach and educational initiatives, diverting resources that could otherwise be allocated to market expansion or technological advancements.

Key Market Trends

The shift towards personalized blood management strategies represents a significant evolution in patient care, moving beyond standardized transfusion protocols to tailored interventions based on individual patient needs. This approach focuses on optimizing a patient's own blood health, minimizing unnecessary transfusions, and thereby reducing associated risks such as infections and adverse reactions. For instance, according to an AABB review of current advances in 2024, treating iron deficiency anemia with intravenous iron significantly reduced postoperative red blood cell transfusions by 70%, improving patient outcomes. This trend influences the market by driving demand for advanced diagnostic tools to assess patient-specific factors like anemia and coagulation status, along with pharmacological alternatives to blood

Key Market Players

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMerieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Blood Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management Market, By Product:

• Instruments
• Accessories
• Reagents & Kits
• Software

Blood Management Market, By Component:

• Whole Blood
• Red Blood Cells
• Plasma

Blood Management Market, By End User:

• Blood Banks
• Hospitals
• Diagnostic Clinics
• Pathology Labs

Blood Management Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Blood Management Market.

Available Customizations:

Global Blood Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Accessories, Reagents & Kits, Software)
  • 5.2.2. By Component (Whole Blood, Red Blood Cells, Plasma)
  • 5.2.3. By End User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Blood Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Component
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe Blood Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Component
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. France Blood Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia Pacific Blood Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Component
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Component
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Blood Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Blood Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. South America Blood Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Component
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Blood Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Blood Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Haemonetics Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fresenius SE & Co. KGaA
• 15.3. Terumo Corporation
• 15.4. Immucor, Inc.
• 15.5. B Braun Melsungen AG
• 15.6. bioMerieux Inc.
• 15.7. Kaneka Corporation
• 15.8. Bio-Rad Laboratories, Inc.
• 15.9. Grifols, S.A.
• 15.10. F. Hoffmann-La Roche Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer